Mr. Tomasz Zieliński | Organic Chemistry | Innovative Research Award

Published on by Chemistry Awards

Mr. Tomasz Zieliński | Organic Chemistry | Innovative Research Award

Mr. Tomasz Zieliński , Organic Chemistry, Nicolaus Copernicus University in Toruń , Poland

Tomasz Zielińsk , is an experienced chemical technologist with over 16 years in the refining and petrochemical industries. Working primarily at ORLEN S.A. in Płock, he’s contributed extensively to production technology, process optimization, and innovative projects enhancing refinery capacities by up to 40%. As an expert in alternative fuels and sustainable technologies, Tomasz serves on several national groups dealing with alternative fuels, climate regulations, and product quality. He’s currently pursuing a Ph.D. at Nicolaus Copernicus University in Toruń, focusing on innovative processes like microbiological hydrocarbon decomposition. With patented technology to produce valuable compounds like isopropanol and hydrogen, he envisions expanding synthetic fuel production to meet EU directives like RED III and Fit for 55. Known for analytical skills, innovative thinking, and leadership in project execution, Tomasz is a key figure driving technological transformation in Poland’s energy sector.

Professional Profile : 

Orcid 

Summary of Suitability for Award:

Developed a patented microbiological process for decomposing hydrocarbon residues into valuable compounds like isopropanol and hydrogen. Proposed using this technology to boost synthetic fuel production and hydrogen integration, contributing to EU climate goals. Successfully resolved critical fuel quality issues (Jet A-1, diesel), safeguarding production reliability and market reputation. Led projects implementing new fuel formulations (e.g. Efecta fuels), demonstrating practical innovation. Strong analytical skills, innovation mindset, project management, and cross-disciplinary collaboration. Demonstrated ability to translate complex research into real-world applications. Tomasz Zieliński’s track record of technological innovations, impactful problem-solving, and visionary research directions positions him as a very strong candidate for the “Innovative Research Award”. His unique blend of industrial experience, scientific research, and successful technology implementations aligns perfectly with the award’s purpose of recognizing groundbreaking contributions that advance industry and sustainability. His work has the potential to contribute significantly to cleaner fuels, process efficiency, and Europe’s climate goals, underscoring his innovative spirit and leadership in his field.

🎓Education:

Tomasz Zieliński’s educational path reflects his dedication to chemical technology and industrial safety. He began at the Zespół Szkół Centrum Edukacji in Płock, where he qualified as a Technician in Chemical Technology (2002-2006). He then earned his Bachelor’s degree in Chemical Technology (specializing in organic technology) at the Warsaw University of Technology (2006-2010). Continuing at the same university, he completed his Master of Engineering in Chemical Technology in 2012. Recognizing the importance of workplace safety, he pursued postgraduate studies in Occupational Health and Safety at the Cracow University of Technology in 2012-2013. Currently, he’s working toward a Ph.D. at Nicolaus Copernicus University in Toruń, diving deeper into innovative chemical processes and technologies. His diverse education equips him with technical expertise, research capabilities, and a keen understanding of industrial standards, crucial for leading advanced projects in the petrochemical sector.

🏢Work Experience:

Over 16 years, Tomasz Zieliński has built a robust career at ORLEN S.A., gaining hands-on and strategic experience. From 2004-2009, he undertook practical training on various installations like Catalytic Cracking, Olefins II, and butadiene production. Between 2009 and 2014, he worked as a Senior Process Operator on the Claus installation. From 2015 to mid-2023, he held the position of Senior Specialist in the Technology Office, tackling complex issues like diesel fuel stability and Jet A-1 fuel quality. Since July 2023, he’s been an Expert in the Project Coordination Team, overseeing efficiency, development, and revitalization projects. Notable achievements include resolving quality problems in fuels, leading technological trials for HVO blending, and coordinating large-scale innovation projects. His experience spans process optimization, analytical testing, project management, and implementation of new technologies, making him an essential contributor to refining and petrochemical advancements.

🏅Awards: 

Although specific official awards weren’t detailed in the CV text, Tomasz Zieliński’s professional record showcases significant achievements and recognition within ORLEN S.A. and the broader industry. His contributions have been acknowledged through leadership roles in critical projects, particularly resolving quality challenges in diesel and jet fuels and pioneering new fuel blends like Efecta. His patented technology for microbiological decomposition of residual hydrocarbons underscores his innovative drive and commitment to sustainability. Participation in national groups under POPIHN (Polish Organization of Oil Industry and Trade) reflects peer recognition of his expertise in alternative fuels, climate policy, and regulatory matters. His ongoing Ph.D. research also highlights academic pursuit and potential future honors. Tomasz’s career is marked by trust and respect from colleagues and industry leaders, testifying to his reputation as a talented, forward-thinking professional dedicated to technological progress and environmental responsibility.

🔬Research Focus:

Tomasz Zieliński’s research centers on sustainable energy and petrochemical innovation. His current Ph.D. work at Nicolaus Copernicus University explores microbiological decomposition of residual hydrocarbons, leading to production of isopropanol and hydrogen — crucial raw materials for petrochemical processes and synthetic fuels. His focus aligns with EU sustainability goals like RED III and Fit for 55, aiming to decarbonize fuel production and optimize refinery operations. Beyond his academic pursuits, Tomasz engages in practical projects, such as integrating hydrogen and synthetic fuel production into ORLEN’s infrastructure, utilizing innovative methods to maximize plant capacities. He’s deeply involved in evaluating fuel quality, blending biocomponents like HVO with diesel, and advancing new fuel formulations. His work bridges industrial application and scientific research, demonstrating how innovative technologies can drive energy transformation and secure Poland’s position in the evolving global energy market.

Publication Top Notes:

🧪 Synthesis of Silver Nanoparticles by Chemical Vapor Deposition Method and Its Application in Laser Desorption/Ionization Techniques

 

Dr. Qunfeng Luo | Organic Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Qunfeng Luo | Organic Chemistry | Best Researcher Award

Dr. Qunfeng Luo , Organic Chemistry ,  Nanchang University, China

Dr. Qunfeng Luo is a dedicated Lecturer at the School of Basic Medical Sciences, Nanchang University, China. With a robust background in organic synthesis and protein chemistry, his research explores innovative approaches in peptide/protein modification and bioorthogonal chemistry. Dr. Luo has made notable contributions to the development of multifunctional bioconjugation reagents and mitochondrion-targeting molecules, with publications featured in top-tier journals like Nature Communications and Organic Letters. He earned his Ph.D. from Nanjing University and has held research positions at prestigious institutions, including Northwestern Polytechnical University. Dr. Luo also brings industry experience from Pharmaron (Ningbo) New Pharmaceutical Technology Co., Ltd. His work bridges chemical biology and therapeutic discovery, particularly focusing on functional biomolecule engineering and natural active ingredient target identification. A proactive researcher with an ORCID profile, he continues to advance translational biomedical science through interdisciplinary innovations.

Professional Profile : 

Orcid

Scopus

Summary of Suitability for Award:

Dr. Luo has demonstrated a solid and progressive academic background, holding a Ph.D. from Nanjing University and postdoctoral experience in both academia and industry. His education from top Chinese institutions equips him with a multidisciplinary foundation in biomedical and pharmaceutical sciences.His research has been published in top-tier journals such as Nature Communications, Organic Letters, and RSC Advances. Notably, his 2019 Nature Communications paper was highlighted in Synfacts, indicating significant recognition in the global scientific community. Dr. Luo’s work spans organic synthesis, peptide/protein modification, mitochondrion-targeting agents, and bioorthogonal chemistry. Dr. Luo has maintained a consistent output of quality research with a clear upward trajectory in the complexity and impact of his work. His continued research activity, mentorship, and involvement in academia strengthen his candidacy. Dr. Qunfeng Luo is a highly suitable candidate for the “Best Researcher Award”. His impactful publications, innovative methodologies in chemical biology, and contributions to targeted therapeutics and diagnostics reflect the qualities sought in a top-tier researcher. His unique blend of academic excellence, industrial insight, and interdisciplinary work makes him not only a prolific scientist but also a future leader in biomedical research. Recognizing Dr. Luo with this award would be both timely and well-deserved.

🎓Education:

Dr. Qunfeng Luo’s academic journey reflects a strong foundation in medical and pharmaceutical sciences. He began his higher education at Harbin Medical University (2005.9–2010.6), where he gained essential knowledge in medical sciences. Building upon this, he pursued a master’s degree at China Pharmaceutical University (2011.9–2014.6), developing a solid base in drug design and bioactive compound synthesis. Driven by a keen interest in chemical biology and therapeutic research, he advanced to Nanjing University (2014.9–2018.12) for his doctoral studies. There, he specialized in organic synthesis and protein/peptide bioconjugation techniques, which laid the groundwork for his current research in bio orthogonal chemistry and target identification. This comprehensive academic training, combining medical, pharmaceutical, and chemical expertise, enables Dr. Luo to contribute significantly to multidisciplinary biomedical research.

🏢Work Experience:

Dr. Qunfeng Luo has held diverse academic and industry positions, enriching his expertise in biomedical sciences. He began his professional journey at Pharmaron (Ningbo) New Pharmaceutical Technology Co., Ltd. (2019.3–2019.9), gaining valuable experience in pharmaceutical R&D. He then transitioned to academia as a research fellow at Northwestern Polytechnical University (2019.9–2020.10), focusing on bioorganic chemistry and molecular modification. Since October 2020, he has served as a Lecturer at the School of Basic Medical Sciences, Nanchang University, where he leads research in peptide modification, mitochondrion-targeting molecules, and functional bioconjugation reagents. Dr. Luo’s balanced experience across academia and industry fosters a translational approach to his research, bridging synthetic chemistry and medical application. His current academic role involves not only high-impact research but also mentoring students and contributing to the university’s biomedical education initiatives.

🏅Awards: 

While specific honors were not detailed, Dr. Qunfeng Luo’s research achievements speak volumes of his recognition in the scientific community. His 2019 Nature Communications publication was highlighted in Synfacts, indicating significant impact in the field of synthetic and chemical biology. Publishing in top-tier journals like Organic Letters and RSC Advances also reflects the high regard in which his work is held. As a young scholar with an innovative portfolio in bioorthogonal chemistry, peptide/protein modification, and mitochondrion-targeting agents, Dr. Luo is well-positioned for future awards and funding opportunities. His diverse background, including experience in pharmaceutical R&D and academia, contributes to his growing influence in biomedical research. As he continues to contribute to high-impact projects and interdisciplinary science, further accolades are expected.

🔬Research Focus:

Dr. Qunfeng Luo’s research lies at the intersection of organic chemistry and biomedical sciences. His primary interests include organic synthesis, peptide and protein modification, and bioorthogonal chemistry—innovative fields that enable precise molecular labeling and therapeutic design. A major focus of his work is developing heterobifunctional cross-linkers that facilitate selective bioconjugation, peptide stapling, and mitochondrial targeting. He also explores target identification of natural active ingredients, contributing to drug discovery and understanding bioactivity mechanisms. His recent publications reveal an emphasis on multifunctional bioconjugation reagents with broad applications in diagnostics and targeted therapies. The integration of small molecule design with functional biomolecules positions his research within both fundamental and translational biomedical innovation. Through interdisciplinary collaborations and advanced chemical techniques, Dr. Luo’s work contributes to the development of precision tools for chemical biology and therapeutic interventions.

Publication Top Notes:

1. Heterobifunctional Cross-Linker with Dinitroimidazole and Azide Modules for Protein and Oligonucleotide Functionalization

2. Heterobifunctional Cross-Linker with Dinitroimidazole and N-Hydroxysuccinimide Ester Motifs for Protein Functionalization and Cysteine–Lysine Peptide Stapling

3. Combination Therapies against COVID-19

4. Dichloroacetophenone Derivatives: A Class of Bioconjugation Reagents for Disulfide Bridging

5. Dinitroimidazoles as Bifunctional Bioconjugation Reagents for Protein Functionalization and Peptide Macrocyclization

6. Recent Advances in Enone and NO-Releasing Derivatives of Oleanolic Acid with Anti-cancer Activity